Lung Cancer Considered

Neurotrophic tyrosine receptor kinase fusion, or NTRK, has emerged in the last six years as a rare, but targetable alteration in several cancers. Dr. Herbert Loong, clinical assistant professor in the...

22 Helmi 202226min

Lung Cancer Considered hosts Dr. Narjust Duma and Dr. Stephen Liu discuss ALK-fusion positive NSCLC with Dr. Jessica Lin, a physician at the Massachusetts General Hospital Cancer Center and an Assista...

15 Helmi 202246min

In this episode of Lung Cancer Considered, host Dr. Stephen Liu talks with Dr. Zosia Piotrowska, Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital in Boston, Mass.,...

1 Helmi 202231min

Cell therapy has made strides in hematology and oncology and has recently shown promise in thoracic oncology. In this episode of Lung Cancer Considered host, Dr. Narjust Duma delves into this emerging...

18 Tammi 202237min

This episode of Lung Cancer Considered focuses on an EGFR mutant non-small cell lung cancer virtual tumor board case that involves a 41-year-old woman who is a never smoker and presents with a dry cou...

4 Tammi 202244min

Dr. Jacques Cadranel, Head of Department Pulmonology and Thoracic Oncology, Assistance Publique Hôpitaux de Paris and Sorbonne University and Dr Janessa Laskin, Medical Oncologist at the Vancouver Can...

28 Joulu 202141min

Dr. Narjust Duma hosts a spirited Spanish-language edition of Lung Cancer Considered on the recently completed 2021 LALCA Schools of Thoracic Oncology meeting with Luis E. Raez, MD, Chief Scientific O...

21 Joulu 202137min

Lung Cancer Considered host Dr. Stephen Liu discusses a virtual tumor board with guests Dr. Anthony Kim, professor of clinical surgery and chief of thoracic surgery at The Keck School of Medicine at t...

7 Joulu 202141min